Back
Fidelity Enhanced Mid Cap ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
74
FMDE
Fidelity Enhanced Mid Cap ETF
Last Price:
$36.85
Seasonality Move:
1.47%
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
$57.90
Seasonality Move:
14.46%
Buy
74
Fidelity Enhanced Mid Cap ETF (FMDE)
is a Buy
Is Fidelity Enhanced Mid Cap ETF a Buy, Sell or Hold?
-
The current Fidelity Enhanced Mid Cap ETF [FMDE] share price is $36.83. The Score for FMDE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
FMDE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $57.91. The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FMDE Stock Price Chart
What is Fidelity Enhanced Mid Cap ETF's stock price today?
-
The Fidelity Enhanced Mid Cap ETF share price today is $36.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FMDE is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $57.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
FMDE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | 254024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.37 - 36.77) | Buy |
| Bollinger Bands (100): | (35.24 - 36.38) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 55.2 | Buy |
| Chaikin Money Flow: | 961654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.1 - 57.32) | Buy |
| Bollinger Bands (100): | (52.47 - 65.41) | Sell |
FMDE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.57 | Buy |
| 20-day SMA: | 36.38 | Buy |
| 50-day SMA: | 35.9 | Buy |
| 200-day SMA: | 34.24 | Buy |
| 8-day EMA: | 36.53 | Buy |
| 20-day EMA: | 36.33 | Buy |
| 50-day EMA: | 36.03 | Buy |
| 200-day EMA: | 34.73 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.29 | Buy |
| 20-day SMA: | 55.44 | Buy |
| 50-day SMA: | 58.65 | Sell |
| 200-day SMA: | 51.17 | Buy |
| 8-day EMA: | 56.26 | Buy |
| 20-day EMA: | 55.99 | Buy |
| 50-day EMA: | 56.42 | Buy |
| 200-day EMA: | 37.76 | Buy |
Fidelity Enhanced Mid Cap ETF Earnings Growth & FMDE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Fidelity Enhanced Mid Cap ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||